Company Overview of BioRexis Pharmaceuticals Corporation
BioRexis Pharmaceuticals Corporation operates as a biopharmaceutical company, which develops and produces biopharmaceuticals. It offers protein and peptide drugs with pharmacology and Trans-bodies to replace conventional monoclonal antibodies. The company’s product includes peptide fusion, which is used for the treatment of type 2 diabetes. It also provides biopharmaceutical products for longer-acting interferon and an erythropoietin receptor agonist. The company was founded in 2002 and is based in King of Prussia, Pennsylvania. As of March 31, 2007, BioRexis Pharmaceuticals Corporation operates as a subsidiary of Pfizer, Inc.
3400 Horizon Drive
King of Prussia, PA 19406
Founded in 2002
Key Executives for BioRexis Pharmaceuticals Corporation
Similar Private Companies By Industry
|IRX Therapeutics, Inc.||United States|
|Hamilton Pharmaceuticals, Inc.||United States|
|Vascular Pharmaceuticals, Inc.||United States|
|Sopherion Therapeutics, LLC||United States|
|Honeywood, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact BioRexis Pharmaceuticals Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.